US Oncology - Rocky Mountain Cancer Center-Boulder — Boulder, Colorado

US Oncology - Rocky Mountain Cancer Center-Boulder is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

US Oncology - Rocky Mountain Cancer Center-Boulder has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Rocky Mountain Cancer Center-Boulder?

US Oncology - Rocky Mountain Cancer Center-Boulder has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Rocky Mountain Cancer Center-Boulder conducted?

US Oncology - Rocky Mountain Cancer Center-Boulder has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is US Oncology - Rocky Mountain Cancer Center-Boulder accredited by Crixeo Health?

US Oncology - Rocky Mountain Cancer Center-Boulder has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Rocky Mountain Cancer Center-Boulder?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.